| scholarly article | Q13442814 |
| P50 | author | Vitor Cabral | Q55344440 |
| Sway Chen | Q57953800 | ||
| Ravi U Sheth | Q87370531 | ||
| P2093 | author name string | Harris H Wang | |
| P2860 | cites work | Concerning RNA-guided gene drives for the alteration of wild populations | Q21128771 |
| Biotechnology. A prudent path forward for genomic engineering and germline gene modification | Q22065510 | ||
| DNA uptake during bacterial transformation | Q22121988 | ||
| Genome-scale engineering for systems and synthetic biology | Q22122302 | ||
| Lateral gene transfer and the nature of bacterial innovation | Q22122396 | ||
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| RNA-guided editing of bacterial genomes using CRISPR-Cas systems | Q24630389 | ||
| Dispersing biofilms with engineered enzymatic bacteriophage | Q24684087 | ||
| Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme | Q27665609 | ||
| Programmable bacteria detect and record an environmental signal in the mammalian gut | Q28236112 | ||
| Fecal microbiota transplantation and emerging applications | Q28255756 | ||
| Ecology of prokaryotic viruses | Q28258560 | ||
| Duodenal infusion of donor feces for recurrent Clostridium difficile | Q28283517 | ||
| Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis | Q29038812 | ||
| Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
| The human microbiome project | Q29547661 | ||
| Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 | ||
| Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria | Q30773032 | ||
| Creating and characterizing communities of human gut microbes in gnotobiotic mice | Q33642679 | ||
| Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity | Q33944259 | ||
| How antibiotics kill bacteria: from targets to networks | Q33958766 | ||
| Biotechnology. Regulating gene drives | Q34041480 | ||
| Prebiotic effects: metabolic and health benefits | Q34141652 | ||
| Growing unculturable bacteria | Q34290686 | ||
| Bacteria from diverse habitats colonize and compete in the mouse gut. | Q34324792 | ||
| Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms. | Q34347048 | ||
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. | Q34374509 | ||
| Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome. | Q34488351 | ||
| Influence of environmental variables in the efficiency of phage therapy in aquaculture | Q34498214 | ||
| Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes. | Q34548512 | ||
| Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs | Q34555151 | ||
| Synthetic biology. Genomically encoded analog memory with precise in vivo DNA writing in living cell populations | Q34702375 | ||
| Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks | Q34987009 | ||
| Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials | Q35050042 | ||
| Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. | Q35163017 | ||
| Recent progress in engineering human-associated microbiomes | Q35170600 | ||
| Viral tagging reveals discrete populations in Synechococcus viral genome sequence space. | Q35209768 | ||
| Genomics of microbial plasmids: classification and identification based on replication and transfer systems and host taxonomy | Q35233714 | ||
| Improving microbial fitness in the mammalian gut by in vivo temporal functional metagenomics | Q35236722 | ||
| Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation | Q35300228 | ||
| Manipulation of the quorum sensing signal AI-2 affects the antibiotic-treated gut microbiota | Q35584736 | ||
| Antibiotics and the developing infant gut microbiota and resistome | Q35737454 | ||
| Genetic determinants of in vivo fitness and diet responsiveness in multiple human gut Bacteroides | Q35796422 | ||
| Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract | Q35812024 | ||
| Predicting a human gut microbiota's response to diet in gnotobiotic mice | Q35829905 | ||
| Programmable probiotics for detection of cancer in urine. | Q35879638 | ||
| High-frequency mobilization of broad-host-range plasmids into Neisseria gonorrhoeae requires methylation in the donor | Q36153783 | ||
| Mobile genetic elements: the agents of open source evolution | Q36247081 | ||
| Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota | Q36602759 | ||
| Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing. | Q36672110 | ||
| Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. | Q36807314 | ||
| Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome | Q37009655 | ||
| Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta | Q37077458 | ||
| Probiotic bacteria influence the composition and function of the intestinal microbiota | Q37111218 | ||
| Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy | Q37114251 | ||
| Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. | Q37406127 | ||
| An extracellular bacterial pathogen modulates host metabolism to regulate its own sensing and proliferation | Q37587866 | ||
| Prebiotics as immunostimulants in aquaculture: a review | Q38224021 | ||
| Broad host range plasmids can invade an unexpectedly diverse fraction of a soil bacterial community | Q39785100 | ||
| Considerations for using bacteriophages for plant disease control | Q41301197 | ||
| Bacteriophage cocktail significantly reduces or eliminates Listeria monocytogenes contamination on lettuce, apples, cheese, smoked salmon and frozen foods | Q41418693 | ||
| A simple and rapid method of bacterial transformation | Q41436363 | ||
| The animal food supplement sepiolite promotes a direct horizontal transfer of antibiotic resistance plasmids between bacterial species | Q41809229 | ||
| Antibiotic administration alters the community structure of the gastrointestinal micobiota. | Q41865163 | ||
| Novel assay to measure the plasmid mobilizing potential of mixed microbial communities | Q41948466 | ||
| A portable expression resource for engineering cross-species genetic circuits and pathways | Q42402390 | ||
| Transposon-aided capture (TRACA) of plasmids resident in the human gut mobile metagenome. | Q42604612 | ||
| Oral treatment of chickens with Lactobacillus reuteri LM1 reduces Brachyspira pilosicoli-induced pathology | Q45263785 | ||
| Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. | Q49073992 | ||
| Ecology drives a global network of gene exchange connecting the human microbiome. | Q51171065 | ||
| Bacteriophage Therapy | Q56389875 | ||
| Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients | Q69370183 | ||
| P433 | issue | 4 | |
| P921 | main subject | microbiome | Q1330402 |
| bacterial community | Q129982151 | ||
| P304 | page(s) | 189-200 | |
| P577 | publication date | 2016-02-22 | |
| P1433 | published in | Trends in Genetics | Q2451468 |
| P1476 | title | Manipulating Bacterial Communities by in situ Microbiome Engineering | |
| P478 | volume | 32 |
| Q64102204 | 2017 NIH-wide workshop report on "The Human Microbiome: Emerging Themes at the Horizon of the 21st Century" |
| Q56995673 | A response to Pennisi - “How do gut microbiomes help herbivores”, a hint into next-generation biocontrol solutions |
| Q44877018 | A transatlantic perspective on 20 emerging issues in biological engineering. |
| Q64101973 | Bottom-Up Approaches to Synthetic Cooperation in Microbial Communities |
| Q41043829 | Brain injury in combination with tacrolimus promotes the regeneration of injured peripheral nerves |
| Q37670475 | Characterization of Batrachochytrium dendrobatidis Inhibiting Bacteria from Amphibian Populations in Costa Rica |
| Q90242627 | Common principles and best practices for engineering microbiomes |
| Q52626796 | Constraint-based modeling in microbial food biotechnology. |
| Q57169429 | Construction and Characterization of Synthetic Bacterial Community for Experimental Ecology and Evolution |
| Q56537156 | Core microbiomes for sustainable agroecosystems |
| Q36171957 | Experimental evolution of rhizobia may lead to either extra- or intracellular symbiotic adaptation depending on the selection regime. |
| Q83229355 | Functional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome |
| Q47108554 | Genetic adaptation of microbial populations present in high-intensity catfish production systems with therapeutic oxytetracycline treatment |
| Q60949607 | Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech |
| Q41552497 | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease |
| Q28079424 | Harnessing Host-Vector Microbiome for Sustainable Plant Disease Management of Phloem-Limited Bacteria |
| Q41693394 | Harnessing microbiome-based biotechnologies for sustainable mitigation of nitrous oxide emissions. |
| Q90371172 | Honey bees harbor a diverse gut virome engaging in nested strain-level interactions with the microbiota |
| Q99551266 | Horizontal 'gene drives' harness indigenous bacteria for bioremediation |
| Q95840390 | Host-microbiota interactions in immune-mediated diseases |
| Q94547117 | Human Adaptation to Deep Space Environment: An Evolutionary Perspective of the Foreseen Interplanetary Exploration |
| Q90632922 | Hypnotic Effects of Lactobacillus fermentum PS150TM on Pentobarbital-Induced Sleep in Mice |
| Q91254629 | Localized recombination drives diversification of killing spectra for phage-derived syringacins |
| Q89454680 | Mechanistic insights into bacterial metabolic reprogramming from omics-integrated genome-scale models |
| Q91045497 | Metagenomic engineering of the mammalian gut microbiome in situ |
| Q64886050 | Metagenomic mining of regulatory elements enables programmable species-selective gene expression. |
| Q36368777 | Microbial nitrous oxide emissions in dryland ecosystems: mechanisms, microbiome and mitigation. |
| Q36245988 | Microbiome and the future for food and nutrient security. |
| Q64063377 | Microencapsulation of -Specific Bacteriophage Felix O1 Using Spray-Drying in a pH-Responsive Formulation and Direct Compression Tableting of Powders into a Solid Oral Dosage Form |
| Q57021885 | Modeling microbial communities from atrazine contaminated soils promotes the development of biostimulation solutions |
| Q39276552 | Ménage à trois in the human gut: interactions between host, bacteria and phages |
| Q36320795 | Opportunistic Sampling of Roadkill as an Entry Point to Accessing Natural Products Assembled by Bacteria Associated with Non-anthropoidal Mammalian Microbiomes. |
| Q40075857 | Phage therapy: An alternative to antibiotics in the age of multi-drug resistance |
| Q36148926 | Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota |
| Q38809833 | Principles for designing synthetic microbial communities |
| Q90374073 | Pseudomonas chlororaphis Produces Multiple R-Tailocin Particles That Broaden the Killing Spectrum and Contribute to Persistence in Rhizosphere Communities |
| Q92089842 | Regulation of Microbiota by Vitamin D Receptor: A Nuclear Weapon in Metabolic Diseases |
| Q50532218 | Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications. |
| Q89682079 | Synthetic Biology for Terraformation Lessons from Mars, Earth, and the Microbiome |
| Q104459115 | Synthetic biology 2020-2030: six commercially-available products that are changing our world |
| Q90215589 | Synthetic gene circuits for the detection, elimination and prevention of disease |
| Q46265536 | The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. |
| Q91580929 | The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay? |
| Q101226292 | The persistence potential of transferable plasmids |
| Q39311810 | Tiny Microbes, Big Yields: enhancing food crop production with biological solutions |
| Q93239182 | Understanding and Engineering Distributed Biochemical Pathways in Microbial Communities |
Search more.